Mike Macnamee, BSc MSc PhD, has more than 20 years scientific and management experience in the field of infertility, rising through clinical embryology/endocrinology to replace Professor Robert Edwards as Scientific Director of Bourn Hall Clinic in 1991 and to General Manager in 2000.
He has worked internationally in the research of reproductive drug development with more than 60 peer-reviewed published papers.
Mike has extensive experience of giving both technical lectures and non-technical presentations to a broad range of audiences at worldwide conferences.
By 2002, he had been promoted to vice-president and head of pre-clinical development within the Serono organisation. At the end of 2005, as Chief Executive, Mike’s commitment to Bourn Hall’s future was demonstrated by his leadership of the management buy-out team in achieving successful independence from its previous pharmaceutical parent. Mike continued as Chief Executive until the Autumn of 2022 when he moved into the role of Chief Advisor to the group of clinics.